Rosacea Medical Management Guidelines

June 2008 | Volume 7 | Issue 6 | Original Article | 531 | Copyright © 2008

James Q. Del Rosso DO, Hilary Baldwin MD, Guy Webster MD

Abstract

Objectives:The objectives of these Guidelines are to provide an overview of the fundamental disease state of rosacea and quality of life implications and outline available pharmacological treatments for rosacea with reference to supporting research and literature. The pharmacological agents discussed are inclusive of those that are FDA-approved based on phase 3 pivotal trials, commonly used agents based on extensive clinical experience, and less commonly used alternatives reported in peerreviewed literature.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles